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Introduction. We evaluate the midterm results of thirty patients who underwent autologous chondrocytes implantation for talus
osteochondral lesions treatment. Materials and Methods. From 2002 to 2009, 30 ankles with a mean lesion size of 2,36cm2 were
treated.WeevaluatedpatientsusingAmericanOrthopaedicFootandAnkleSurgeryandCoughlinscore,VanDijkscale,recovering
time, and Musculoskeletal Outcomes Data Evaluation and Management System. Results. The mean AOFAS score varied from 36.9
to 83.9 at follow-up. Average of Van Dijk scale was 141.1. Coughlin score was excellent/good in 24 patients. MOCART score varied
from 6.3 to 3.8. Discussion. This matrix is easy to handle conformable to the lesion and apply by arthroscopy. No correlation
between MRI imaging and clinical results is found. Conclusions. Our results, compared with those reported in literature with other
surgical procedures, show no superiority evidence for our technique compared to the others regarding the size of the lesions.
1.Introduction
Ankle sprain is the most common trauma in sports, and an
osteochondral lesion occurs, in up to 50% of an acute ankle
trauma [1, 2]. Every day 1 out of 10000 people undergoes
to an ankle injury, and in sports practice, this incidence
becomes 5,23 out of 10000 [3–5]. The incidence of these
lesions is more frequent in male (70%), with an average age
ranging between 20 and 30 years, and is bilateral in 10%
of cases [6]. The symptoms are impaired function, limited
range of motion, stiﬀness, ankle pain even after a mild trau-
matic event, or chronic ankle pain [7, 8].
Therearealsono traumaticcausesofosteochondral talus
lesions: chronic instability, endocrine or metabolic factors,
joint malalignment, idiopathic avascular necrosis particu-
larly dumping growth age, degenerative joint diseases, sys-
temic vasculopathies, and genetic predisposition [9–16].
Osteochondral lesions were classiﬁed by Berndt and
Harty [17] in 1959 (X-ray classiﬁcation), modiﬁed by
Loomer et al. [18] in 1993 (CT scan classiﬁcation), but
many other classiﬁcations have been developed, including
the arthroscopic outerbridge classiﬁcation that is commonly
used in clinical practice [19–24]. Only the MRIcanassess the
cartilage damage and other soft tissue lesions [25–27].
The aim of this study was to evaluate the midterm results
of a series of patients who have undergone autologous chon-
drocytes implantation for the treatment of osteochondral
lesions of the talus with MACI (Matrix-induced Autologous
Chondrocytes Implantation) technique.
Conservative treatments for osteochondral lesions are
diﬀerent, having the aim to improve symptoms and improv-
ing function, leading to spontaneous healing in early stages
andinyoungersubjects,whilesurgicaltreatmentisindicated
in case of failure of conservative treatment. The use of autol-
ogous chondrocytes implants with 3-dimensional matrices
seems to have allowed a breakthrough in the treatment of
cartilage lesion and we propose this technique in lesion types
3 and 4 according to the outerbridge classiﬁcation [19].
Surgicaltreatmentforpainfulosteochondrallesionofthe
ankle is increased over the last years. The aim of surgical
treatment is the defect revascularization stimulating the
formation of a ﬁbrous scar or the reconstruction of the
cartilage layer [20, 28–30].2 Advances in Orthopedics
Diﬀerent surgical procedures, as described in literature,
ﬁnd their indication depending on the type of lesion, so
that the decision-making process requires a careful physical
evaluation and an instrumental assessment to determine the
right choice [31–33].
2.MaterialsandMethods
This study was approved by the institutional review board.
From 2002 to 2009, 30 ankles in the same amount of
patients were treated for osteochondral lesions of the talus.
The inclusion criteria in this study were patients aﬀected
by a posttraumatic and non traumatic osteochondritis dis-
secans, aged more than 16 years old and less than 50, osteo-
chondrallesionssizedmorethan1.5cm2 andlessthan4cm2.
Patients with history of arthritis or previous surgical
procedures, overweight patients, “kissing lesions”, patients
aged more than 50 years, diabetic or HCV patients, and
rheumatologic pathology were excluded.
15 patients were men and 15 women, the age ranging be-
tween17and49yearsold(averageage28,9)atthetimeofthe
procedure; the right ankle was aﬀected in 20 patients, the left
in 10 patients.
25 patients had a traumatic events and complained pain
and functional impairment, with a lateral instability for
chronic ligament injury in 6 cases. 5 patients present non
traumatic osteochondritis dissecans.
Preoperatively standard X-rays and an MRI were per-
formed [25–27] and lesions were classiﬁed according to the
Outerbridge classiﬁcation [19], appearing to be as type 3 or
4,correspondingtotype2or2AaccordingtoGiannini’setal.
classiﬁcation [20], with a mean size of 2,36cm2 ± 0,49cm2.
18 cases (60%) out of 30 were centromedial dome lesions,
7 cases (23,3%) out of 30 were centrolateral lesions, 3 cases
(10%) out of 30 were posteromedial lesions, while 2 lesions
(6,7%) were antero medial (Table 1).
We used a MACI (Matrix-induced Autologous Chon-
drocytes Implantation) Hyaﬀ 11 (Verigen, Leverk¨ usen, Ger-
many) in all patients. These 3-dimensional matrices are
composed by resorbable natural collagen derived from
bovine tissue that facilitate cells expansion in the cartilage
defect. The matrix has two surfaces, one appearing smooth
and one rougher: in this latter chondrocytes are seeded.
A single surgeon performed all of the procedures.
The surgical technique was performed in 2 steps, both
with spinal anesthesia, in supine position with ﬂexed knee
and dangling leg. The 1st step consisted in harvesting a small
portion of cartilage arthroscopically from the site of the
lesion for chondrocytes culture storing it in vitro with nutri-
ent medium and shipping to Verigen laboratories together
with 100mL of venous patient’s blood where chondrocytes
development occurs on the 3-dimensional standard size
matrix in about 20 days. The 2nd step took place after about
30 days. During this procedure the graft was cut according to
thedimensionofthetemplateobtaineddirectlyonthelesion,
implanted and ﬁxed with ﬁbrin glue (Figures 1 and 2). The
size of the lesions at MRI was conﬁrmed intraoperatively.
Table 1: Patient’s data: age, gender, side, and size of lesion.
Age Gender (M/F) Side (L/R) Lesion size (cm2)
33 M L 1,8
31 M R 2,4
25 W R 1,7
29 M R 2,5
17 M L 2,1
25 W R 2,0
21 W R 2,8
31 W L 3,7
28 M R 2,2
22 W L 1,8
35 M L 2,6
30 W R 2,5
29 M R 1,6
28 W R 2,5
27 M L 2,3
19 M R 2,6
49 W L 2,8
32 M R 3,1
41 W L 2,3
28 M R 2,7
22 W R 2,1
38 M R 2,1
33 M R 2,5
22 W R 3,2
24 M L 1,8
23 W R 2,2
31 W L 1,7
25 M R 1,9
29 W R 2,5
40 W R 2,8
In 25 patients the implant was performed by an arthro-
scopic approach. Three cases required a medial malleolar
osteotomy that was ﬁxed with 1screw (Figure 3) because of a
large posteromedial osteochondral lesion of the talus. In the
ﬁrst 2 cases the lesion was treated by an anterior arthrotomy
(Figure 4)[34]becausethearthroscopicapproachduringthe
learning curve was not successful for the graft implantation.
In 6 ankles (15,4%) out of 30 a lateral ligament recon-
struction with a Brostrom-Gould procedure was combined
[35, 36]; in addition, in 5 ankles (12,8%) out of 30 a sub-
chondral morcellised bone transplant was performed be-
cause of the deep bone degeneration. In the other 2 cases a
heel osteotomy to realign the hindfoot and a distraction ar-
throplasty with external ﬁxation were associated.
Postoperatively patients used crutches without weight-
bearing for one week after the 1st surgical procedure and for
4 weeks after the second one. A second look for arthroscopic
synovectomy was needed in 4 cases for impingement of soft
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Figure 1: The chondrocytes matrix (arrow) was placed on the
cartilage lesion during the 2nd surgical step.
Figure 2: In the 2nd step, after about 30 days, the chondrocytes
(arrow) were implanted on the lesion, ﬁxing the matrix with ﬁbrin
glue.
Figure 3: A medial malleolar osteotomy with subsequent ﬁxation
of the osteotomy with 1 screw was required in 3 cases to approach
in a posteromedial osteochondral lesion of the talus, not suitable by
arthroscopy.
Figure 4: A small arthrotomy was necessary in 2 cases for the
achievement of the lesion and the placement of the 3-dimensional
matrix with cultured chondrocytes (MACI).
We clinically evaluated all patients before surgery and
at follow-up using the American Orthopaedic Foot and
Ankle Surgery (AOFAS) Ankle-Hindfoot scale score system
(rating as excellent the results with a score of more than 80,
good with a score range between 61 and 80 points, insuf-
ﬁcient when the score was less than 60) [37]. The visual
analog scale proposed by Van Dijk et al. (range, 1–190
points; considering positive results when the score was above
114; graded by summing the scores obtained by 19 speciﬁc
questions) [38], patient’s subjective satisfaction according to
the method proposed by Coughlin (range, 1–4 points) [39],
and information about return to work or sport (range, 0–1
points) were also evaluated at the ﬁnal follow-up.
Furthermore, for what concerns the MRI, all patients
were assessed with the MOCART score (magnetic resonance
observation of cartilage repair tissue score) (range, 0–7
points)thatisconsideredtobeanindexofthegraft’sintegra-
tion and its quality [40]. With respect to the osteochondral
lesion, it attributes 0 or 1 point for the ﬁlling degree, the
graft’s integration, the lamina’s integrity, and for subchon-
dral bone edema; it also assigns 0 to 3 points for MRI signal
intensity of the graft’s cartilage. It is rated as excellent graft’s
integrationwithascoreof0,goodwithascorerangebetween
1a n d2p o i n t s ,a n ds u ﬃc i e n tw i t has c o r er a n g eb e t w e e n3
and 5 points, insuﬃcient when the score was more than 6.
The preoperative clinical and imaging scores were cor-
related with the results of the ﬁnal follow-up using the
Student’s t-test. A P value < 0.05 was considered signiﬁcant.
Statistical analysis was performed using Microsoft Oﬃce
Excel (2007 version).
3. Results
Theaveragefollow-upwas45months(range,18–96months).
All patients reported reduction or lack of the pain in the
ankle area that they had experienced prior to the operation.
The mean total AOFAS score varied from 36,9 ± 6,6
points (range, 30 to 52 points) preoperatively to 83,9 ± 13,6
points (range, 50 to 100 points) at follow-up (P<0,01).
We obtain excellent results in 17 patients (56,7%) out of 30,
goodresultsin11patients(36,7%)outof30,andinsuﬃcient
results in 2 cases (6,6%) (Table 2 and Figure 5).4 Advances in Orthopedics
Table 2: AOFAS, VAS, Coughlin, and MOCART scores’ mean values before surgery and at follow-up.
Score Preop. average ± sd Follow-up average ± sd
AOFAS (0–100) 36,9 ± 6,6 83,9 ± 13,6
VAS (0–190) 141,1 ± 35,6
COUGHLIN (1–4) 3,1 ± 0,8
MOCART (0–7) 6,3 ± 0,8 3,8 ± 0,9
6.6%
36.7%
56.7%
Excellent >80 p.ti
Good 61–80 p.
Fair >60 p.
A.O.F.A.S. score (0–100)
PRE OP: 36.9 points
Post OP: 83.9 points
Figure 5: AOFAS score at ﬁnal follow-up.
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Figure 6: AOFAS score trend during follow-up.
The AOFAS score trend during follow-up remained lin-
ear (Figure 6).
The pain score was 40 points of the 40-point maximum
on the AOFAS Ankle-Hindfoot scale in 11 patients (36,7%)
out of 30, 16 patients (53,3%) out of 30 had occasional mild
pain scoring 30 points, while 3 cases (10%) had moderate
pain with 20 points.
The functional capacity, which was graded by summing
the scores for seven diﬀerent aspects of functional perfor-
mance of the scale, averaged 41,9 ± 7,3 points (maximum
score on the scale, 50 points), due to the fact that 2 patients
(7%)outof30complainedofankle-hindfootinstability with
activity limitation.
Visual analogic scale (Van Dijk)
Average 141,1 ± 35.6
(Positive ≥114)
Insuﬃcient
26.7%
Positive
73.3%
Figure 7: VAS score at ﬁnal follow-up.
The maximum score for ankle-hindfoot alignment (10
points, indicating excellent or good alignment) was recorded
for 24 ankles (80%); a mild, asymptomatic hindfoot
malalignment (an AOFAS score of 8 points) was recorded
for 5 ankles (16,7%). Only 1 patient had a symptomatic
malalignment. The overall mean score for ankle-hindfoot
alignment was 9,3 ± 1,9 points.
The average of the Van Dijk’s Visual Analog Scale (VAS)
was 141,1 ± 35,6 points (maximum score on the scale, 190
points) graded by summing the scores for the 19 diﬀerent
questions (Table 1). According to this score we obtained 22
positive results (73,3%) and 8 insuﬃcient results (26,7%)
(Table 1 and Figure 7).
The patient subjective satisfaction of the patients was
sortable as excellent in 11 patients (36,7%), good in 13
(43,3%), fair in 5 patients (16,7%), and insuﬃcient in 1
(3,3%) (Table 1 and Figure 8).
With regard to the MRI ﬁndings, the preoperatively
MOCART score was 6,3 while it became 3,8 at follow-up.
This means a good integration of the cartilage graft (Table 1
and Figures 9 and 10).
Fifteenpatients(50%)returnedtoprevioussportswithin
2 months after the surgery, in 8 cases (26,7%) out of 30
sporting activities werenot possible for ankle pain, while in 7
patients (23,3%) the no return to sport was not related with
clinical outcome (Figure 10).
No major complications as avascular necrosis of the talus
or deep infection were observed; 2 anterior impingement
and 2 failures of the graft with recurrent lesions occurred
in 4 ankles (13,3%) which required an arthroscopic second
look. In all these 4 cases the biopsy’s histological result was
ﬁbrocartilage.Advances in Orthopedics 5
36.7%
43.3%
16.7%
3.3%
Coughlin score 
Excellent satisfaction
Good satisfaction
Fair satisfaction
Poor satisfaction
Figure 8: Patient satisfaction Coughlin score at ﬁnal follow-up.
The preoperative and ﬁnal follow-up AOFAS and
MOCART scores were correlated using the Student’s t-test
ﬁnding a P value nonsigniﬁcant.
4. Discussion
In literature many authors reported diﬀerent treatments of
the osteochondral lesion [31, 32], but a true comparison
between studies is diﬃcult considering the diﬀerent rating
scales used, as indicated by Zengerink et al. in a meta-
analysis [33], in which so many scores as AOFAS Ankle-
Hindfoot scale, Hannover score, patient satisfaction score,
criteria proposed by Berndt and Harty, visual analog scale,
Martin score, Alexander and Lichtman, Ogilvie Harris score,
MODEMS (Musculoskeletal Outcomes Data Evaluation and
Management System), Karlsson scoring scale, Tegner score,
evaluation proposed by Loomer, Mazur score, Freiburg
ankle score, SANE (Single Assessment Numeric Evaluation),
according to Thompson and Loomer, and McCullough score
are used for clinical assessment.
Traumatic cartilage fragments that have not detached
from the bone can be treated with stabilization by pins or
screws [41, 42].
The medial dome lesions are more common and larger
thanlateral,thetwomostcommontalussitesofinjurybeing,
respectively, centromedial and centrolateral. Posteromedial
and anterolateral lesions are rare [34]. Only 17% of the
medial lesions and 20% of the lateral need an osteotomic
access, and diﬀerent studies describe medial malleolar oste-
otomy access [43–45]. Depending on the treatment methods
a precise reduction and ﬁxation of the bone window with 1
or 2 screws is fundamental.
When cartilage remains intact on the subchondral bone
lesion, retrograde drilling can be performed to protect the
integrity of the articular cartilage. Outcome studies have
shown good results [46–48]. Some authors injected, in liquid
form, calcium sulfate into the lesion after drilling, as bone
substitute [49].
Microfracture or microdrilling has the aim to stimulate
the development of ﬁbrocartilage increasing the serum
factors on the subchondral plate that leads to ﬁbrous tissue
formation at the defect site and symptomatic relief for the
patient [50]. The new angiogenesis is by this way stimulated,
bone marrow cells are introduced in the osteochondral
defect, and ﬁbrocartilaginous tissue is formed. Studies
indicate this technique of bone marrow stimulation (BMS)
as optimal in small lesion (diameter less than 15mm) with
chondral damage, but not subchondral bone involvement
[30, 42, 51, 52].
Tissue transplantation today includes diﬀerent tech-
niques that are most widely used. Often the surgeons
utilize perpendicular access to the injured area to allow the
transplant into the talus.
For larger talar injury a Mosaicplasty proposed by
Hangodyetal.canbeperformed[53].Thelesionmustha v ea
surface of no more than 4cm2 and about 10mm in diameter.
This technique utilizes cylindrical osteochondral plugs taken
from the nonweightbearing femoralsegment of the knee that
are transferred to a talar dome defect. Diﬀerent studies have
showngoodandexcellentresultsin94%ofthecases[53–55].
Another technique for larger cystic osteochondral lesion
isOsteochondralAutologousTransferSystem(OATS).When
the lesion is more than 6mm of diameter, there is the
conversion from arthroscopy to open surgery, often with
medialmalleolarosteotomy.Alsointhiscasegoodresultsare
reported in literature [56, 57].
Osteochondral Allograft Transplantation is usually uti-
lized for very large lesions, when the size of the lesion is more
than 3cm3. The advantage of this technique is the correct
sizing of the graft, which is done intraoperatively with direct
measurement. The allograft is often held in place by screw
ﬁxation [58–60].
TheACItechnique(AutologousChondrocytesImplanta-
tion)wasdevelopedbyBrittbergetal.andPetersonetal.[61,
62].Itincludes thesutureofaperiostealﬂaptotherimofthe
debrided chondral defect. We can consider MACI technique
(Matrix—induced Autologous Chondrocytes Implantation)
as an ACI evolution. The advantages of these 3-dimensional
matrices are that they are easier to handle and apply,
they are conformable to the lesion without the need of
periosteal coveraging, and it is possible to apply them by an
arthroscopicapproach.Thisisthetechniquedescribedinthis
study.
The disadvantages can be found in the need of 2 surgical
steps, higher costs, more recovery time, and some limits
in the treatment of deep lesions, in which an additional
bone graft could be necessary, and some diﬃculties in new
chondrocytes proliferation control [33].
Our results, according to AOFAS score [37], Van Dijk’s
et al. visual analogic scale (VAS) [38], Coughlin score
[39], information about return to work or sport, and the
MOCART score [40], are comparable to the results reported
in literature [20, 29, 30].
While a preoperative subjective patients’ satisfaction
Coughlin score cannot be assessed, the lack of the preoper-
ative VAS Van Dijk’s score represents a limit of the study.
In the Zengerink et al. review [33] 4 studies with the
ACI technique for a total of 59 patients were discussed. In6 Advances in Orthopedics
(a)
P
(b)
(c) (d)
Figure 9: (a, b, c, d) Clinical case: 38-years-old man with anteromedial osteochondral lesion of the talus. Preoperative MRI images (a, b).
AOFAS score was 30 points. (c, d) MRI images at follow-up (36 months). AOFAS score was 90 points.
Return within 2 months
Don’t return due to ankle pain
Don’t return due to other reasons
50%
26.7%
23.3%
Return to previous sport activity
Figure 10: Return to previous sport activity.
45 of 59 cases (76%; range: 70 to 92%) a successful result was
reported.
Giannini et al. with ACI technique in 8 patients and a
mean follow-up of 26 months obtained an increase of the
mean AOFAS score from 32,1 preoperatively to 91 postop-
eratively [28].
According to the literature’s results in prospective ran-
domized studies, the ACI technique showed better results in
cartilage lesions with a size of more than 3cm2, when com-
pared with mosaicplasty and microfracture technique [63–
65].
There are not yet superiority evidence of the MACI tech-
nique we applied compared to the ACI technique. This may
also be due to assessment methods. Most of the studies use
the AOFAS score, which is very “functional” but not speciﬁc;
it relates to common daily activities [37].
If we judge the results based on the Van Dijk score or on
Coughlin’s degree of subjective satisfaction, we would see
lower excellent and good results.
It is therefore still not possible to adequately compare the
two surgical techniques.
Also with MACI technique, as in Brittberg et al. and
Peterson et al. technique (ACI) [61, 62], the disadvantage are
the 2 surgical steps, in which the 2nd sometimes required aAdvances in Orthopedics 7
malleolar osteotomy access or anterior arthrotomy, and the
cost/beneﬁtsratioofthesurgicaltechniquethat,accordingto
the diﬀerent scores used in the studies, cannot be accurately
validated.
There are new methods that are still under study.
Mesenchymal Stem Cells (MSCs) from bone marrow
have been cultured in vitro and have been used in hybrid
scaﬀolds to repair osteochondral defects [66–68].
Platelet-rich plasma is characterized by red blood cells,
white blood cells, and platelets in a ﬁbrin matrix, where
platelet-derived growth factor, insulin-like growth factor,
and TGF-β are included. This clot is poured into the lesion
site [69, 70].
Tissue engineering has been proposed for the tissue re-
generation using biomaterials, cells, and factors alone or to-
gether. Three options have been described: extraction of the
patient’s cells, vitro cultures, and then transplantation; util-
ization of biologic factors as growth factors; and use of 3-di-
mensional porous materials to stimulate the tissue in-
growths [71, 72].
As summarized by Van Dijk et al., ACI/MACI tech-
nique is a relatively expensive technique, while OATS gives
morbidity from knee complained by up to 36% of patients
in literature. On the other hand, arthroscopic excision,
curettage, and BMS are relatively inexpensive, with a low
morbidity, a quick recovery, and a high success rate (85%).
According to these facts and based on a non-obvious
superiority of one surgical technique over the other, BMS
should be still considered as the treatment of choice for type
3 and 4 osteochondral talar lesions, while in lesions with a
size of more than 1,5cm2, ACI-MACI techniques should be
considered in order to achieve better results with cartilage
reconstruction.
5. Conclusions
Three-dimensional matrices can be considered for single
Outerbridge lesions type 3 or 4, sized more than 1,5cm2,
patients aged less than 50 years without degenerative chan-
ges. Contraindications are overweight patients, “kissing le-
sions”,patientsagedmorethan50years,diabeticorHCVpa-
tients, and rheumatologic pathology.
No correlation between MRI imaging and clinical results
is found, while histology has shown the formation of hybrid
cells between cartilage and ﬁbrocartilage. Probably the
marrow edema, generally an inﬂammation expression, may
be caused by a vascular repair hyperﬂow. Autologous chon-
drocyte implantation showed consistently better ﬁll of the
defects at all times compared with microfracture [73]. Nev-
ertheless MRI remains the gold standard for the instru-
mental monitoring, according to its high sensibility and tol-
erability and to its noninvasive and accurate imaging with
dedicated scores [63].
The results of this study, however when compared with
those reported in literature with other surgical procedures,
show that there is not yet a superiority evidence for ACI/
MACI technique against microfracture and microdrilling or
OATS regardless of the size of the lesions [31–33].
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